{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:09:43Z","timestamp":1782234583342,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T00:00:00Z","timestamp":1382832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T00:00:00Z","timestamp":1382832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11908-013-0382-9","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T07:14:30Z","timestamp":1382771670000},"page":"594-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Advances in Infectious Encephalitis: Etiologies, Outcomes, and Potential Links with Anti-NMDAR Encephalitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Arun","family":"Venkatesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,27]]},"reference":[{"key":"382_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:114\u201328","journal-title":"Clin Infect Dis"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/367841","volume":"36","author":"CA Glaser","year":"2003","unstructured":"Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis. 2003;36:731\u201342.","journal-title":"Clin Infect Dis"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1086\/516301","volume":"26","author":"H Kolski","year":"1998","unstructured":"Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis. 1998;26:398\u2013409.","journal-title":"Clin Infect Dis"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0022-510X(01)00441-5","volume":"184","author":"T Rantalaiho","year":"2001","unstructured":"Rantalaiho T, Farkkila M, Vaheri A, Koskiniemi M. Acute encephalitis from 1967 to 1991. J Neurol Sci. 2001;184:169\u201377.","journal-title":"J Neurol Sci"},{"key":"382_CR5","first-page":"449","volume":"11","author":"SR Irani","year":"2011","unstructured":"Irani SR, Vincent A. Autoimmune encephalitis \u2013 new awareness, challenging questions. Discov Med. 2011;11:449\u201358.","journal-title":"Discov Med."},{"key":"382_CR6","first-page":"366","volume":"18","author":"MR Rosenfeld","year":"2012","unstructured":"Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn). 2012;18:366\u201383.","journal-title":"Continuum (Minneap Minn)."},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"D Nash","year":"2001","unstructured":"Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807\u201314.","journal-title":"N Engl J Med"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMp1210537","volume":"367","author":"LR Petersen","year":"2012","unstructured":"\u2022 Petersen LR, Fischer M. Unpredictable and difficult to control\u2013the adolescence of West Nile virus. N Engl J Med. 2012;367:1281\u20134. This editorial highlights some of the major challenges in defining the epidemiologyof West Nile virus, predicting outbreaks, and developing vaccines.","journal-title":"N Engl J Med"},{"key":"382_CR9","first-page":"513","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. West nile virus and other arboviral diseases - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:513\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"382_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3201\/eid1901.121135","volume":"19","author":"MS Nolan","year":"2013","unstructured":"Nolan MS, Schuermann J, Murray KO. West Nile virus infection among humans, Texas, USA, 2002-2011. Emerg Infect Dis. 2013;19:137\u20139.","journal-title":"Emerg Infect Dis"},{"key":"382_CR11","first-page":"19508","volume":"15","author":"P Reiter","year":"2010","unstructured":"Reiter P. West Nile virus in Europe: understanding the present to gauge the future. Euro Surveill. 2010;15:19508.","journal-title":"Euro Surveill."},{"key":"382_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-ento-112408-085419","volume":"55","author":"WK Reisen","year":"2010","unstructured":"Reisen WK. Landscape epidemiology of vector-borne diseases. Annu Rev Entomol. 2010;55:461\u201383.","journal-title":"Annu Rev Entomol"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1297-9716-43-16","volume":"43","author":"M De Filette","year":"2012","unstructured":"De Filette M, Ulbert S, Diamond M, Sanders NN. Recent progress in West Nile virus diagnosis and vaccination. Vet Res. 2012;43:16.","journal-title":"Vet Res"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0002-9343(73)90226-X","volume":"54","author":"R Price","year":"1973","unstructured":"Price R, Chernik NL, Horta-Barbosa L, Posner JB. Herpes simplex encephalitis in an anergic patient. Am J Med. 1973;54:222\u20138.","journal-title":"Am J Med"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1258\/0956462041724163","volume":"15","author":"D Grover","year":"2004","unstructured":"Grover D, Newsholme W, Brink N, Manji H, Miller R. Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients. Int J STD AIDS. 2004;15:597\u2013600.","journal-title":"Int J STD AIDS"},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0046-8177(98)90038-7","volume":"29","author":"D Schiff","year":"1998","unstructured":"Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol. 1998;29:215\u201322.","journal-title":"Hum Pathol"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1212\/WNL.0b013e3182752ceb","volume":"79","author":"IL Tan","year":"2012","unstructured":"\u2022 Tan IL, McArthur JC, Venkatesan A, Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology. 2012;79:2125\u201332. This case\u2013control study includes the largest series of patients with HSE in immunocompromised patients and is the first to directly compare the presentation between immunocompromised and immunocompetent states.","journal-title":"Neurology"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"JA Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010;362:402\u201315.","journal-title":"N Engl J Med"},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM199408183310703","volume":"331","author":"CB Hall","year":"1994","unstructured":"Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994;331:432\u20138.","journal-title":"N Engl J Med"},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMoa042207","volume":"352","author":"DM Zerr","year":"2005","unstructured":"Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005;352:768\u201376.","journal-title":"N Engl J Med"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/00007890-200204150-00012","volume":"73","author":"HJ MacLean","year":"2002","unstructured":"MacLean HJ, Douen AG. Severe amnesia associated with human herpesvirus 6 encephalitis after bone marrow transplantation. Transplantation. 2002;73:1086\u20139.","journal-title":"Transplantation"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1212\/01.wnl.0000265591.10200.d7","volume":"69","author":"WW Seeley","year":"2007","unstructured":"Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69:156\u201365.","journal-title":"Neurology"},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","volume":"47","author":"AR Tunkel","year":"2008","unstructured":"Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303\u201327.","journal-title":"Clin Infect Dis"},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jmv.23470","volume":"85","author":"F de Ory","year":"2013","unstructured":"de Ory F, Avellon A, Echevarria JE, et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol. 2013;85:554\u201362.","journal-title":"J Med Virol"},{"key":"382_CR25","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1086\/509330","volume":"43","author":"CA Glaser","year":"2006","unstructured":"Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565\u201377.","journal-title":"Clin Infect Dis"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/00006454-199611000-00017","volume":"15","author":"Y Xu","year":"1996","unstructured":"Xu Y, Zhaori G, Vene S, et al. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr Infect Dis J. 1996;15:1018\u201324.","journal-title":"Pediatr Infect Dis J"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jmv.20399","volume":"76","author":"KN Ward","year":"2005","unstructured":"Ward KN, Thiruchelvam AD, Couto-Parada X. Unexpected occasional persistence of high levels of HHV-6 DNA in sera: detection of variants A and B. J Med Virol. 2005;76:563\u201370.","journal-title":"J Med Virol"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.21611","volume":"65","author":"K Yao","year":"2009","unstructured":"Yao K, Honarmand S, Espinosa A, Akhyani N, Glaser C, Jacobson S. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol. 2009;65:257\u201367.","journal-title":"Ann Neurol"},{"key":"382_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/clinids\/21.3.571","volume":"21","author":"JA McCullers","year":"1995","unstructured":"McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis. 1995;21:571\u20136.","journal-title":"Clin Infect Dis"},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1756285612456234","volume":"5","author":"U Meyding-Lamad\u00e9","year":"2012","unstructured":"Meyding-Lamad\u00e9 U, Strank C. Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord. 2012;5:279\u201396.","journal-title":"Ther Adv Neurol Disord"},{"key":"382_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jmv.1890470119","volume":"47","author":"M Luppi","year":"1995","unstructured":"Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol. 1995;47:105\u201311.","journal-title":"J Med Virol"},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/JCM.02115-06","volume":"45","author":"KN Ward","year":"2007","unstructured":"Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol. 2007;45:1298\u2013304.","journal-title":"J Clin Microbiol"},{"key":"382_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/rmv.715","volume":"22","author":"PE Pellett","year":"2012","unstructured":"\u2022\u2022 Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012;22:144\u201355. This is an important and timely review on current methodologies and challenges in distinguishing HHV6 chromosal integration from viral reactivation.","journal-title":"Rev Med Virol"},{"key":"382_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-720-4_1","volume":"900","author":"A Perl","year":"2012","unstructured":"Perl A. Pathogenesis and spectrum of autoimmunity. Methods Mol Biol. 2012;900:1\u20139.","journal-title":"Methods Mol Biol"},{"key":"382_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"19","author":"RS Fujinami","year":"2006","unstructured":"Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19:80\u201394.","journal-title":"Clin Microbiol Rev"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1177\/0883073812451327","volume":"27","author":"RC Dale","year":"2012","unstructured":"Dale RC, Brilot F. Autoimmune basal ganglia disorders. J Child Neurol. 2012;27:1470\u201381.","journal-title":"J Child Neurol"},{"key":"382_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mus.20762","volume":"35","author":"N Yuki","year":"2007","unstructured":"Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve. 2007;35:691\u2013711.","journal-title":"Muscle Nerve"},{"key":"382_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63\u201374.","journal-title":"Lancet Neurol"},{"key":"382_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11\u20138.","journal-title":"Ann Neurol"},{"key":"382_CR40","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10096-009-0799-0","volume":"28","author":"MS Gable","year":"2009","unstructured":"Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"382_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/PCC.0b013e3181cf4652","volume":"11","author":"SA Baltagi","year":"2010","unstructured":"Baltagi SA, Shoykhet M, Felmet K, Kochanek PM, Bell MJ. Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med. 2010;11:179\u201384.","journal-title":"Pediatr Crit Care Med"},{"key":"382_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2377-11-149","volume":"11","author":"CL Xu","year":"2011","unstructured":"Xu CL, Liu L, Zhao WQ, et al. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up. BMC Neurol. 2011;11:149.","journal-title":"BMC Neurol"},{"key":"382_CR43","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ana.23689","volume":"72","author":"H Pr\u00fcss","year":"2012","unstructured":"\u2022\u2022 Pr\u00fcss H, Finke C, Holtje M, et al. N-methylD-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012;72:902\u201311. This retrospective analysis of 44 CSF PCR positive HSE patients found that 13 patients (30%) had antibodies to the NMDA receptor in either serum or CSF and is the first to suggest a potential relationship between HSE and anti-NMDAR encephalitis.","journal-title":"Ann Neurol"},{"key":"382_CR44","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1212\/WNL.0b013e3181fc2a06","volume":"75","author":"H Pr\u00fcss","year":"2010","unstructured":"Pr\u00fcss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735\u20139.","journal-title":"Neurology"},{"key":"382_CR45","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","volume":"78","author":"H Pr\u00fcss","year":"2012","unstructured":"Pr\u00fcss H, H\u00f6ltje M, Maier N, et al. IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology. 2012;78:1743\u201353.","journal-title":"Neurology"},{"key":"382_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-5-31","volume":"5","author":"M Manto","year":"2010","unstructured":"Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J. In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis. 2010;5:31.","journal-title":"Orphanet J Rare Dis"},{"key":"382_CR47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1086\/341405","volume":"35","author":"F Raschilas","year":"2002","unstructured":"Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002;35:254\u201360.","journal-title":"Clin Infect Dis"},{"key":"382_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJM198601163140303","volume":"314","author":"RJ Whitley","year":"1986","unstructured":"Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314:144\u20139.","journal-title":"N Engl J Med"},{"key":"382_CR49","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1086\/648419","volume":"49","author":"A Mailles","year":"2009","unstructured":"Mailles A, Stahl JP. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis. 2009;49:1838\u201347.","journal-title":"Clin Infect Dis"},{"key":"382_CR50","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00415-013-6986-z","volume":"260","author":"IL Tan","year":"2013","unstructured":"Tan IL, Mowry EM, Steele SU, et al. Brainstem encephalitis: etiologies, treatment, and predictors of outcome. J Neurol. 2013;260:2312\u20139.","journal-title":"J Neurol"},{"key":"382_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"\u2022 Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. In this multicenter observational study, over 500 patients with anti-NMDAR encephalitis were followed for a median of 24 months, and treatment effects and outcomes were assessed.","journal-title":"Lancet Neurol"},{"key":"382_CR52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.0b013e3182a2cc6d","volume":"81","author":"KT Thakur","year":"2013","unstructured":"Thakur KT, Motta M, Asemora AO, et al. Predictors of outcome in acute encephalitis. Neurology 2013;81:793\u2013800.","journal-title":"Neurology"},{"key":"382_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2006.04.002","volume":"71","author":"RJ Whitley","year":"2006","unstructured":"Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71:141\u20138.","journal-title":"Antiviral Res."},{"key":"382_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jnnp.63.3.321","volume":"63","author":"N McGrath","year":"1997","unstructured":"McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"382_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1086\/380458","volume":"38","author":"M Emig","year":"2004","unstructured":"Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis. 2004;38:289\u201392.","journal-title":"Clin Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-013-0382-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0382-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:56:26Z","timestamp":1744149386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-013-0382-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,27]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s11908-013-0382-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,27]]},"assertion":[{"value":"27 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}